Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-05 @ 10:29 PM
Study NCT ID:
NCT03403751
Status:
TERMINATED
Last Update Posted:
2021-10-12
First Post:
2018-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Sponsor:
Atox Bio Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-24
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-06
First Submit QC Date:
None
Study First Post Date:
2018-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-18
Results First Submit QC Date:
None
Results First Post Date:
2021-09-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-01-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-09-17
Last Update Post Date:
2021-10-12
Last Update Post Date Type:
ACTUAL